Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherCONTINUING EDUCATION

Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy

K. Laxman Parthasarathy and Elpida S. Crawford
Journal of Nuclear Medicine Technology December 2002, 30 (4) 165-171;
K. Laxman Parthasarathy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elpida S. Crawford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Instructions

    Patient instructionsDuration (d)
    1.11–3.7 GBq* (30–100 mCi)3.7–5.55 GBq* (100–150 mCi)5.55–7.4 GBq* (150–200 mCi)
    To reduce external exposure to others
     Limit time spent in public places234
     Limit private travel (at 0.914-m separation of >2 h)123
     Do not travel by mass transportation or airplane234
     Do not travel on prolonged automobile trip with others234
     Delay returning to work if workplace or office is shared234
     Avoid prolonged close contact with children and pregnant women456
     Sleep in separate bed (>1.829-m separation)456
     Flush used facial tissues down the toilet (flush toilet, at least twice, after urination)456
    To minimize transfer of 131I or internal exposure
     Avoid mouth-to-mouth contact456
     Do not share items that contact mouth or saliva (e.g., eating utensils, water/pop/beer bottles/cans, etc.)456
     Use separate towels and washcloths456
     Use regular utensils and plates and wash them separately456
     Wash your hands thoroughly after going to toilet (use separate bathroom, if possible, and men should also sit down while urinating)345
    • ↵* Treatment dose range.

    • Based on NRC Regulatory Guide 8.39 and James E. Carey, Jr., MS, DABR presentations at Society of Nuclear Medicine meetings and local presentation in December 1998.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 30 (4)
Journal of Nuclear Medicine Technology
Vol. 30, Issue 4
December 1, 2002
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
K. Laxman Parthasarathy, Elpida S. Crawford
Journal of Nuclear Medicine Technology Dec 2002, 30 (4) 165-171;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
K. Laxman Parthasarathy, Elpida S. Crawford
Journal of Nuclear Medicine Technology Dec 2002, 30 (4) 165-171;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Radioiodine Therapy
    • General Principle Behind Ablative Therapy and Treatment of Metastases Using 131I
    • Patient Preparation for Therapy with Sodium 131I-Iodide
    • Selection and Management of Outpatients Receiving High-Dose 131I
    • Side Effects or Complications of 131I Therapy for Thyroid Carcinoma
    • Follow-Up of Patients After 131I Therapy
    • Prognostic Factors of Survival
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 131I in Blood Samples: A Danger for Professionals? A Problem for Immunoassays?
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire